Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $109.68 in the prior trading day, Axsome Therapeutics Inc (NASDAQ: AXSM) closed at $102.55, down -6.50%. In other words, the price has decreased by -$6.50 from its previous closing price. On the day, 1.12 million shares were traded. AXSM stock price reached its highest trading level at $110.19 during the session, while it also had its lowest trading level at $102.54.
Ratios:
Our goal is to gain a better understanding of AXSM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.96 and its Current Ratio is at 2.03. In the meantime, Its Debt-to-Equity ratio is 3.97 whereas as Long-Term Debt/Eq ratio is at 3.93.
On June 03, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $185.
On April 07, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $200.Jefferies initiated its Buy rating on April 07, 2025, with a $200 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 20 ’25 when Murdock Hunter R. sold 7,500 shares for $102.47 per share. The transaction valued at 768,525 led to the insider holds 0 shares of the business.
Murdock Hunter R. sold 6,014 shares of AXSM for $602,122 on Jun 23 ’25. The General Counsel now owns 0 shares after completing the transaction at $100.12 per share. On Jun 23 ’25, another insider, Murdock Hunter R., who serves as the Officer of the company, bought 6,014 shares for $100.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXSM now has a Market Capitalization of 5049192960 and an Enterprise Value of 5310566400. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.68 while its Price-to-Book (P/B) ratio in mrq is 94.86. Its current Enterprise Value per Revenue stands at 12.289 whereas that against EBITDA is -22.993.
Stock Price History:
The Beta on a monthly basis for AXSM is 0.52, which has changed by 0.20321488 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, AXSM has reached a high of $139.13, while it has fallen to a 52-week low of $72.21. The 50-Day Moving Average of the stock is -3.88%, while the 200-Day Moving Average is calculated to be -1.52%.
Shares Statistics:
The stock has traded on average 638.64K shares per day over the past 3-months and 684200 shares per day over the last 10 days, according to various share statistics. A total of 49.22M shares are outstanding, with a floating share count of 40.44M. Insiders hold about 17.86% of the company’s shares, while institutions hold 74.78% stake in the company. Shares short for AXSM as of 1751241600 were 4083784 with a Short Ratio of 6.39, compared to 1748563200 on 3883989. Therefore, it implies a Short% of Shares Outstanding of 4083784 and a Short% of Float of 9.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
